Søgning på udtrykket 'pneumoni' giver 58 resultater
Dokumenter [5] Sider [2] Kalender [10] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [5]
1. udgave, forventes opdateret i løbet af 2022. Retningslinjerne er udarbejdet af en arbejdsgruppe med repræsentanter fra Dansk Lungemedicinsk Selskab og Dansk Selskab for Infektionsmedicin.
Version 8 (21.11.22) Udarbejdet af Dansk Selskab for Infektionsmedicin i samarbejde med Dansk Selskab for Klinisk Mikrobiologi, Dansk Hæmatologisk Selskab, Dansk Pædiatrisk Selskab, Dansk Selskab for Almen Medicin, Dansk Lungemedicinsk Selskab, Dansk Selskab for Obstetrik og Gynækologi, Dansk Transplantationsselskab, Dansk Selskab for Klinisk Onkologi & Fagligt Selskab for Hygiejnesygeplejersker
Ændringer siden sidste udgave: 1. Simplificering af risikogrupper. 2. Skærpelse af kriterier for opstart af behandling hos indlagte patienter, f.eks. blodgas analyse før remdesivir. 3. Information om høj pris på paxlovid og højere NNT for beskyttelse mod alvorligt forløb siden primærpublikation.
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: Remdesivir står ikke længere som relativt kontraindiceret ved påvirket nyrefunktion.
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: 1. Et af Paxlovid kriterierne ændret (fra ”Betydelige symptomer på COVID-19” til ”Mild eller moderat COVID-19”). 2. Døde links til infektionshygiejniske retningslinjer er fjernet, og nyt er indsat. 3. Tekst om afisolation.
Sider [2]
…iese. Osteomyelitis: Nis Pedersen Jørgensen (tovholder), Nina Weis, Terese Katzenstein, Pernille Ravn, Lotte Ebdrup, Henrik Nielsen, Theis Aagaard og Michala Kehler Guidelines for diagnostik og behandling af spondylodiskitis, Pneumoni: Christian Philip Fischer (tovholder), Sebastian Von Huth, Lars Toft, Lone Mygind, Camilla Hatleberg, Thomas Benfield Pneumoni, Post-COVID-19: Jacob Bodilsen, Christian Brandt, Stine Johnsen, Terese Katzenstein, Anne Øvrehus, …
…cu Johansen. 13.45-14.45. Lunge absces, empyem og Aspergillus. Formaliserede indlæg. Plenumdiskussion. Christian Laursen. 14.45-15.00. Pause. . . 15.00-16.00. Non-infektiøse pneumonier. Formaliserede indlæg. Plenumdiskussion. Jesper Davidsen. 16.00-16.15. Opsamling og evaluering. . Anbefalet læsning: TB og non-tuberkuløse mykobakterier. "Tuberkulose - diagnostik og beha…
…ndgrens studie af, hvornår man kan holde op med at give pneumocyste-profylakse til HIV-smittede eller de Gans studiet, der ændrede fik indført dexamethason i retningslinjerne for purulent meningitis. Her er formentlig et nyt studie, der kommer til at få indflydelse på standardbehandlingen af patienter med svær pneumoni. Læs en gang - og døm selv - jeg tager den med til næste års "Journal Highlights of the year", men tænkte at den måske allerede nu var god at få kendskab til. God læselyst :-)
Kalender [10]
21. marts, Fredericia
17. marts, Online og Cape Town, Sydafrika
10. maj 2023, Mærsk Tårnet, Panum Instituttet
6. maj 2022, Hindsgavl, Middelfart
16. juni 2021, Online
26. november 2018, Liverpool, England
9. november 2018, Korsør
12. oktober 2018, Nordsjællands Hospital Hillerød
9. marts 2018, Auditoriet, Nordsjællands Hospital Hillerød
2. april 2014, Cape Town, Sydafrika
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Infection
26.04.2024
… Abstract. . Purpose. Antibodies against SARS-CoV-2 spike (anti-S) may confer protection against symptomatic COVID-19. Whether their level predicts progression among those with COVID-19 pneumonia remains unclear. . . . Methods. We conducted a retrospective cohort study to assess predictors of anti-S levels and whether anti-S titer is associated with death or mech…
Virulence
25.04.2024
Volume 15, Issue 1, December 2024 .
Journal of Infectious Diseases
24.04.2024
Abstract . Background . K. pneumoniae is capable of resistance to β-lactam antibiotics through expression of β-lactamases (both chromosomal and plasmid-encoded) and downregulation of outer membrane porins. However, the extent to which these mechanisms interplay in a resistant phenotype is not well understood. The purpose of this study was to determine the extent to which β-lactamases and outer membrane porins affected β-lactam resistance.Methods . MICs to β-lactams and inhibitor combinations were deter…
BMC Infectious Diseases
24.04.2024
. Abstract. . Background. Carbapenem-resistant Klebsiella pneumoniae (CRKP) infections are a major public health problem, necessitating the administration of polymyxin E (colistin) as a last-line antibiotic. Meanwhile, the mortality rate associated with colistin-resistant K. pneumoniae infections is seriously increasing. On the other hand, importance of administration of carbapenems in promoting colistin resistance in K. pne…
Infection
23.04.2024
… Abstract. . Purpose. Antibodies against SARS-CoV-2 spike (anti-S) may confer protection against symptomatic COVID-19. Whether their level predicts progression among those with COVID-19 pneumonia remains unclear. . . . Methods. We conducted a retrospective cohort study to assess predictors of anti-S levels and whether anti-S titer is associated with death or mech…
BMC Infectious Diseases
23.04.2024
. Abstract. . Objective. To compare the similarities and differences between patients with Coronavirus Disease 2019 (COVID-19) and those with other community-acquired pneumonia (CAP) admitted to the intensive care unit (ICU), utilizing propensity score matching (PSM), regarding hospitalization expenses, treatment options, and prognostic outcomes, aiming to inform the diagnosis and treatment of COVID-19. . …
BMC Infectious Diseases
20.04.2024
. Abstract. . Background. Lobar pneumonia caused by Mycoplasma pneumoniae is a relatively difficult-to-treat pneumonia in children. The time of radiographic resolution after treatment is variable, a long recovery time can result in several negative effects, and it has attracted our attention. Therefore, exploring factors associated with delayed radiographic resolution will help to identify these children at an early stage an…
BMC Infectious Diseases
20.04.2024
. Abstract. . Background. Lobar pneumonia caused by Mycoplasma pneumoniae is a relatively difficult-to-treat pneumonia in children. The time of radiographic resolution after treatment is variable, a long recovery time can result in several negative effects, and it has attracted our attention. Therefore, exploring factors associated with delayed radiographic resolution will help to identify these children at an early stage an…
Clinical Microbiology and Infection
18.04.2024
We have read with interest the paper by Garzoni et al (1).The authors observed un unexpected increase of the number of cases of severe pneumonia due to M. pneumoniae in adults since November 2023.
Emerg Microbes Infect
17.04.2024
Volume 13, Issue 1, December 2024 .
Infection and Immunity
17.04.2024
Infection and Immunity, Ahead of Print.
Infection and Immunity
17.04.2024
Infection and Immunity, Ahead of Print.
American Journal of Respiratory and Critical Care Medicine
15.04.2024
American Journal of Respiratory and Critical Care Medicine, Volume 209, Issue 8, Page 903-904, April 15, 2024.
American Journal of Respiratory and Critical Care Medicine
15.04.2024
American Journal of Respiratory and Critical Care Medicine, Volume 209, Issue 8, Page 973-986, April 15, 2024.
American Journal of Respiratory and Critical Care Medicine
15.04.2024
American Journal of Respiratory and Critical Care Medicine, Volume 209, Issue 8, Page 1019-1022, April 15, 2024.
BMJ Open
12.04.2024
. Objectives. To estimate all-cause mortality in ventilator-associated pneumonia (VAP) and determine whether antibiotic duration beyond 8 days is associated with reduction in all-cause mortality in patients admitted with VAP in the intensive care unit. . Design. A prospective cohort study of patients diagnosed with VAP based on the National Healthcare Safety Network definition and clinical criteria. . Setting. Single tertiary care hospital in Southern India. . Participants. 100 consecutive adult patients…
Infection and Immunity
10.04.2024
Infection and Immunity, Ahead of Print.
Critical Care Explorations
6.04.2024
OBJECTIVES: . We postulate that corticosteroid-related side effects in critically ill patients are similar across sepsis, acute respiratory distress syndrome (ARDS), and community-acquired pneumonia (CAP). By pooling data across all trials that have examined corticosteroids in these three acute conditions, we aim to examine the side effects of corticosteroid use in critical illness. DATA SOURCES: . We performed a comprehensive search of MEDLINE, Embase, Centers for Disease Control and Prevention library o…
Clinical Microbiology and Infection
6.04.2024
Pneumocystis jirovecii pneumonia (PCP) is a common opportunistic infection among people living with HIV (PLWH), particularly among new and untreated cases. Several regimens are available for the prophylaxis of PCP including trimethoprim-sulfamethoxazole (TMP-SMX), dapsone-based regimens (DBRs), aerosolized pentamidine (AP), and atovaquone.
International Journal of Infectious Diseases
5.04.2024
Streptococcus pneumoniae asymptomatically colonizes the nasopharynx, often causes pneumococcal disease in children and adults, and can enter the bloodstream to cause invasive pneumococcal disease (IPD). The most common presentation is bacteremic pneumonia, which accounts for approximately 60% of all adult IPD cases [1]. Adult patients with bacteremic pneumococcal pneumonia have a higher in-hospital mortality rate than those without bacteremia [2]. Therefore, understanding the diverse clinical aspects of pne…
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Eurosurveillance latest updates
19.04.2024
In 2023, an increase of OXA-48-producing Klebsiella pneumoniae was noticed by the Lithuanian National Public Health Surveillance Laboratory. Whole genome sequencing (WGS) of 106 OXA-48-producing K. pneumoniae isolates revealed three distinct clusters of carbapenemase-producing K. pneumoniae high-risk clones, including sequence type (ST) 45 (n = 35 isolates), ST392 (n = 32) and ST395 (n = 28), involving six, six and nine hospitals in different regions, respectively. These results enabled targeted…
Morbidity and Mortality Weekly Report (MMWR)
22.02.2024
This report describes an increase in Mycoplasma pneumoniae, a common cause of respiratory illness, beginning in fall 2023.
Medscape Infectious Diseases
15.02.2024
The ECDC has called for mitigating actions in the face of more European Union and European Economic Area countries reporting hypervirulent Klebsiella pneumoniae ST23. . Medscape Medical News
Medscape Infectious Diseases
26.01.2024
Exblifep is as effective as piperacillin-tazobactam in the treatment of complicated urinary tract infections, the European Medicines Agency said. . Medscape Medical News
Eurosurveillance latest updates
26.01.2024
Mycoplasma pneumoniae is an important cause of pneumonia and extra-pulmonary manifestations. We observed a rise in admissions due to M. pneumoniae infections starting October 2023 in a regional hospital in the Netherlands and an increased incidence in national surveillance data. The incidence in the Netherlands has not been that high since 2011. The patients had a lower median age compared with 2019 and 2020 (28 vs 40 years). M. pneumoniae should be considered in patients with respiratory symptoms, especial…
Eurosurveillance latest updates
12.01.2024
We report a surge of patients, especially children and adolescents, with respiratory disease caused by Mycoplasma pneumoniae in Denmark since October 2023. While the surge has reached an epidemic level, no impact on hospital capacity has been observed; only 14% (446/3,195) of cases, primarily adults, required hospitalisation. Macrolide resistance was detected in less than 2% of samples tested. Timely monitoring of hospitalisations linked to M. pneumoniae infections has been established to inform the healthc…
Eurosurveillance latest updates
24.11.2023
. Background. Preliminary unpublished results of the survey of carbapenem- and/or colistin-resistant Enterobacterales (CCRE survey) showed the expansion of carbapenemase-producing Klebsiella pneumoniae (CPKP) sequence type (ST) 39 in 12 of 15 participating Greek hospitals in 2019. . . Aim. We conducted a rapid survey to determine the extent of spread of CPKP high-risk clones in Greek hospitals in 2022 and compare the distribution of circulating CPKP clones in these hospitals since 2013. . . Methods. We …
Eurosurveillance latest updates
20.10.2023
. Background. Since 2021, an emergence of New Delhi metallo-β-lactamase (NDM)-14-producing Klebsiella pneumoniae has been identified in France. This variant with increased carbapenemase activity was not previously detected in Enterobacterales. . . Aim. We investigated the rapid dissemination of NDM-14 producers among patients in hospitals in France. . . Methods. All NDM-14-producing non-duplicate clinical isolates identified in France until June 2022 (n = 37) were analysed by whole genome sequencin…
Eurosurveillance latest updates
20.10.2023
New Delhi metallo-beta-lactamase (NDM)-producing Klebsiella pneumoniae (Kp) ST147 caused a large multi-hospital outbreak in Italy from 2018 to 2021. We describe a new ST6668 NDM-producing Kp clone, belonging to CC147, which rapidly spread across hospitals in the Pavia province (Northern Italy) from February to August 2023. Genomic analyses revealed that ST6668 is different from ST147 and fast evolving. As shown here, genomic surveillance programmes are useful for tracking the spread of new clones with reduc…
Medscape Infectious Diseases
26.09.2023
New research from Northwestern University and the University of Wisconsin, however, is pointing to bacterial pneumonia as the cause of many severe COVID deaths. . WebMD Health News
Medscape Infectious Diseases
19.09.2023
Clinicians should consider all three etiologies on community-acquired pneumonia presentation to improve antimicrobial stewardship and patient outcomes. . CDC Expert Commentary
ProMED
13.05.2023
Pneumonia -- IraqFollowing a surge in meningitis cases in Halabjah City and Sulaymaniyah governorate since mid-April 2023, an expert team from the World Health Organization (WHO) and the Ministry of Health was deployed to the affected areas to perform a joint epidemiological investigation of the reported cases and develop a swift response plan to curb the transmission of the disease.Preliminary laboratory results from 24 collected samples showed a mixture of bacterial (_Streptococcus pneumoniae_) and viral
ProMED
7.05.2023
…fection -- United StatesA bacterial outbreak at Virginia Mason Medical Center in Seattle has sickened 31 patients since October [2022]. Seven of them have since died, but it's unknown what caused those deaths -- the infection or the diagnoses that brought them to the hospital in the first place._Klebsiella pneumoniae_ is a bacterium usually found in health care settings, and often resistant to antibiotics. It can cause pneumonia, meningitis, and wound or bloodstream infections.Virginia Mason is working with
ProMED
28.04.2023
Klebsiella pneumoniae -- United StatesFour patients at a downtown Seattle hospital are dead in connection to an outbreak of a bacterium often found in healthcare settings that has developed resistance to some antibiotics.The [31] infected patients, who contracted _Klebsiella_, were hospitalized in various departments, including inpatient medical beds, an ICU, and an operating room at Virginia Mason Medical Center, the hospital said in a statement released Wednesday [26 Apr 2023].Beginning in October 2022, h…
Eurosurveillance latest updates
28.04.2023
A hypervirulent Klebsiella pneumoniae SL218 (ST23-KL57), phylogenetically distinct from the classical hypervirulent SL23 (ST23-KL1) lineage, was transmitted between hospitalised patients in Denmark in 2021. The isolate carried a hybrid resistance and virulence plasmid containing blaNDM-1 and a plasmid containing blaOXA-48 (pOXA-48); the latter plasmid was horizontally transferred within-patient to Serratia marcescens. The convergence of drug resistance and virulence factors in single plasmids and in differe…
Eurosurveillance latest updates
15.12.2022
In 2022, German surveillance systems observed rapidly increasing numbers of NDM-1- and NDM-1/OXA-48-producing Klebsiella pneumoniae, which may in part reflect recurring pre-pandemic trends. Among these cases, however, a presence in Ukraine before diagnosis was frequently reported. Whole genome sequencing of 200 isolates showed a high prevalence of sequence types ST147, ST307, ST395 and ST23, including clusters corresponding to clonal dissemination and suggesting onward transmission in Germany. Screening and…
Eurosurveillance latest updates
10.11.2022
…allow identification of novel bacterial species. This can affect surveillance of infections and antimicrobial resistance. From 2017, increasing numbers of medical microbiology laboratories in Switzerland differentiated Klebsiella variicola from Klebsiella pneumoniae complex using updated MALDI-TOF databases, whereas many laboratories still report them as K. pneumoniae or K. pneumoniae complex. Aim. Our study explored whether separate reporting of K. variicola and the Klebsiella pneumoniae complex affected t…
ProMED
31.10.2022
Hospital-Related Infection -- Jamaica
Eurosurveillance latest updates
27.10.2022
A nosocomial outbreak by cefiderocol (FDC)-resistant NDM-1-producing Klebsiella pneumoniae (NDM-Kp) occurred in a large tertiary care hospital from August 2021–June 2022 in Florence, Italy, an area where NDM-Kp strains have become endemic. Retrospective analysis of NDM-Kp from cases observed in January 2021–June 2022 revealed that 21/52 were FDC-resistant. The outbreak was mostly sustained by clonal expansion of a mutant with inactivated cirA siderophore receptor gene, which exhibited high-level…
ProMED
25.10.2022
Animal Die-off --